» Articles » PMID: 22977022

Radiation Necrosis in the Brain: Imaging Features and Differentiation from Tumor Recurrence

Overview
Journal Radiographics
Specialty Radiology
Date 2012 Sep 15
PMID 22977022
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation necrosis in the brain commonly occurs in three distinct clinical scenarios, namely, radiation therapy for head and neck malignancy or intracranial extraaxial tumor, stereotactic radiation therapy (including radiosurgery) for brain metastasis, and radiation therapy for primary brain tumors. Knowledge of the radiation treatment plan, amount of brain tissue included in the radiation port, type of radiation, location of the primary malignancy, and amount of time elapsed since radiation therapy is extremely important in determining whether the imaging abnormality represents radiation necrosis or recurrent tumor. Conventional magnetic resonance (MR) imaging findings of these two entities overlap considerably, and even at histopathologic analysis, tumor mixed with radiation necrosis is a common finding. Advanced imaging modalities such as diffusion tensor imaging and perfusion MR imaging (with calculation of certain specific parameters such as apparent diffusion coefficient ratios, relative peak height, and percentage of signal recovery), MR spectroscopy, and positron emission tomography can be useful in differentiating between recurrent tumor and radiation necrosis. In everyday practice, the visual assessment of diffusion-weighted and perfusion images may also be helpful by favoring one diagnosis over the other, with restricted diffusion and an elevated relative cerebral blood volume being seen much more frequently in recurrent tumor than in radiation necrosis.

Citing Articles

Long-term impact of bevacizumab for the treatment of brain radiation necrosis.

Nobel H, Ofer J, Borenstein S, Limon D, Gal O, Laviv Y J Neurooncol. 2025; .

PMID: 40072807 DOI: 10.1007/s11060-025-04979-1.


Re-irradiation followed by resection for recurrent brain metastases after initial stereotactic radiosurgery: illustrative cases.

Kato T, Hasegawa T, Kuwabara K, Ohno M, Kuramitsu S, Naito T J Neurosurg Case Lessons. 2025; 9(7).

PMID: 39961102 PMC: 11833232. DOI: 10.3171/CASE24737.


Predicting glioblastoma progression using MR diffusion tensor imaging: A systematic review.

Cozzi F, Mayrand R, Wan Y, Price S J Neuroimaging. 2024; 35(1):e13251.

PMID: 39648937 PMC: 11626419. DOI: 10.1111/jon.13251.


Preoperative PET imaging and fluorescence-guided surgery of human glioblastoma using dual-labeled antibody targeting ET receptors in a preclinical mouse model: A theranostic approach.

Hautiere M, Vivier D, Dorval P, Pineau D, Kereselidze D, Denis C Theranostics. 2024; 14(16):6268-6280.

PMID: 39431005 PMC: 11488107. DOI: 10.7150/thno.98163.


The complementary role of MRI and FET PET in high-grade gliomas to differentiate recurrence from radionecrosis.

Sahu A, Mathew R, Ashtekar R, Dasgupta A, Puranik A, Mahajan A Front Nucl Med. 2024; 3:1040998.

PMID: 39355021 PMC: 11440952. DOI: 10.3389/fnume.2023.1040998.